Article metrics

Download PDFPDF

Protocol
Safety and efficacy of PCSK9 inhibitor (evolocumab) in patients with non-ST segment elevation acute coronary syndrome and non-culprit artery critical lesions: a randomised controlled trial protocol (SPECIAL study)

 

Online download statistics by month:

Online download statistics by month: July 2024 to June 2025

AbstractFullPdf
Jul 2024791786198
Aug 202438737989
Sep 202433432247
Oct 202435635048
Nov 202435734461
Dec 202433333264
Jan 202512811341
Feb 202520019277
Mar 202512312067
Apr 202512912095
May 202511811164
Jun 2025242510
Total32803194861